Status: Recruiting
Replacement of the Native Mitral Valve Using the ReValve System
This study is to collect preliminary chronic information on performance and safety of the ReValve System.
Participants needed: 25
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: ReValve Solutions Inc.Updated: May 22, 2026Locations: 2
Eligibility criteria
Symptomatic functional and/or degenerative MR (≥2+) due to ischemic and non-isch... [+4]
Untreated clinically significant coronary artery disease requiring revasculariza... [+7]